{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Biosimilars vs. Originators: A Comprehensive Guide for Nurses on Efficacy, Safety, and Patient Care
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Learning Objectives
After completing this continuing education activity you will be able to:
- Identify the processes that manufacturers use to produce biosimilar medications.
- Compare and contrast biologic with biosimilar medications.
- Discuss nursing implications when providing teaching to patients who will start taking a biosimilar medication.
Learning Outcomes
By the conclusion of this activity, a majority of the participants will demonstrate knowledge of biosimilar medications by achieving a passing score on the posttest.Disclosures
All authors and planners have no relevant financial relationships with any ineligible organizations regarding this educational activity.
Price:
$21.95
Credits:
- ANCC 2.0 CH
- DC - BON 2.0 CH
- FL - BON 2.0 CH
- GA - BON 2.0 CH
- NM - BON 2.0 CH
- SC - BON 2.0 CH
- WV - BOERN 2.0 CH
Lippincott Professional Development is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: N1224B
Published: Dec 2024
Expires: 12/4/2026
Sources:
Nursing 2025
Required Passing Score: 8/10 (80%)
Categories:
Acute Care
,
Drug Therapy